doi: 10.1007/s00595-007-3706-2
10.1186/s12916-024-03274-6 Summary Keywords GLP-1 receptor agonists, FAERS, adverse events, metabolism and nutrition disorders, pharmacovigilance Citation He L, Li Q, Yang Y, Li J, Luo W, Huang Y and Zhong X (2024) Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
Cch ung glutathione ng chun: Ung trc khi ng 1-2 gi , sau n ti t nht 1 ting
Asthma: Individuals with asthma should approach injectable glutathione cautiously, as some case reports have suggested potential for respiratory symptoms in susceptible individuals, though the mechanism and frequency of this effect remain unclear
First synthesized at the University of Arizona in the 1980s, MT1 is currently being studied for its potential to aid in mitigating skin disorders